These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16142707)

  • 1. Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score.
    van Rossum MA; Boers M; Zwinderman AH; van Soesbergen RM; Wieringa H; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; van Luijk WH; Oostveen JC; Kuis W; Dijkmans BA;
    Arthritis Rheum; 2005 Sep; 52(9):2865-72. PubMed ID: 16142707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.
    van Rossum MA; Fiselier TJ; Franssen MJ; Zwinderman AH; ten Cate R; van Suijlekom-Smit LW; van Luijk WH; van Soesbergen RM; Wulffraat NM; Oostveen JC; Kuis W; Dijkstra PF; van Ede CF; Dijkmans BA
    Arthritis Rheum; 1998 May; 41(5):808-16. PubMed ID: 9588731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method.
    van Rossum MA; Zwinderman AH; Boers M; Dijkmans BA; van Soesbergen RM; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; Kuis W; van Luijk WH; Oostveen JC; Dijkstra PF;
    Arthritis Rheum; 2003 Feb; 48(2):507-15. PubMed ID: 12571861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
    Ringold S; Chon Y; Singer NG
    Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
    van Rossum MA; van Soesbergen RM; Boers M; Zwinderman AH; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; van Luijk WH; Oostveen JC; Kuis W; Dijkmans BA;
    Ann Rheum Dis; 2007 Nov; 66(11):1518-24. PubMed ID: 17491099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
    Clarke AE; St-Pierre Y; Joseph L; Penrod J; Sibley JT; Haga M; Genant HK
    J Rheumatol; 2001 Nov; 28(11):2416-24. PubMed ID: 11708412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.
    Al-Matar MJ; Petty RE; Tucker LB; Malleson PN; Schroeder ML; Cabral DA
    Arthritis Rheum; 2002 Oct; 46(10):2708-15. PubMed ID: 12384930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.
    Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
    Arthritis Rheum; 2004 Apr; 50(4):1083-96. PubMed ID: 15077290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?
    Butbul YA; Tyrrell PN; Schneider R; Dhillon S; Feldman BM; Laxer RM; Saurenmann RK; Spiegel L; Cameron B; Tse SM; Silverman ED
    J Rheumatol; 2009 Sep; 36(9):2033-41. PubMed ID: 19648305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis.
    Huemer C; Malleson PN; Cabral DA; Huemer M; Falger J; Zidek T; Petty RE
    J Rheumatol; 2002 Jul; 29(7):1531-5. PubMed ID: 12136915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
    Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
    Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ILAR criteria for juvenile idiopathic arthritis.
    Krumrey-Langkammerer M; Häfner R
    J Rheumatol; 2001 Nov; 28(11):2544-7. PubMed ID: 11708431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis.
    Felici E; Novarini C; Magni-Manzoni S; Pistorio A; Magnani A; Bozzola E; Buoncompagni A; Martini A; Ravelli A
    J Rheumatol; 2005 Sep; 32(9):1805-10. PubMed ID: 16142881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis.
    Magnani A; Pistorio A; Magni-Manzoni S; Falcone A; Lombardini G; Bandeira M; Rossi F; Sala I; Martini A; Ravelli A
    J Rheumatol; 2009 Mar; 36(3):628-34. PubMed ID: 19208600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
    Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a single value score to assess global range of motion in juvenile idiopathic arthritis.
    Epps H; Hurley M; Utley M
    Arthritis Rheum; 2002 Aug; 47(4):398-402. PubMed ID: 12209486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for arthroscopic synovectomy in oligoarticular juvenile idiopathic arthritis?
    Toledo MM; Martini G; Gigante C; Da Dalt L; Tregnaghi A; Zulian F
    J Rheumatol; 2006 Sep; 33(9):1868-72. PubMed ID: 16881093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis.
    Magni-Manzoni S; Ruperto N; Pistorio A; Sala E; Solari N; Palmisani E; Cugno C; Bozzola E; Martini A; Ravelli A
    Arthritis Rheum; 2008 Aug; 59(8):1120-7. PubMed ID: 18668599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.